Latest Biotech News

Multiple clinical updates reflect ongoing advances in oncology, including Blacksmith Medicines securing a patent for antibacterial compounds targeting LpxC, Hemispherian receiving orphan drug...

Recent financial developments include Concentra Biosciences acquiring struggling biotech IGM Biosciences as part of an ongoing buyout streak and Innovent Biologics raising HKD 4.3 billion ($547...

Recent comprehensive studies led by Columbia University and published in major journals forecast a significant rise in uterine cancer incidence and mortality in the United States over the next 25...

Concentra Biosciences, under hedge fund Tang Capital, has continued its aggressive acquisition strategy, picking up struggling biotech IGM Biosciences for $1.25 per share. This marks Concentra's...

Tempus AI increased its convertible senior notes offering from $400 million to $650 million to manage debt and reduce interest expenses. The Chicago-based precision medicine company offered notes...

Imagene AI, a Miami-based firm developing AI-enabled digital pathology tools, secured $23 million in a Series B financing round led by Oracle's Larry Ellison. The company uses advanced foundation...

Moderna announced top-line results from its Phase 3 trial of the mRNA-1010 seasonal influenza vaccine, showing a 26.6% relative vaccine efficacy compared to a licensed standard-dose shot in adults...

AbbVie announced the acquisition of Capstan Therapeutics for up to $2.1 billion, gaining access to Capstan’s in vivo CAR-T platform and its phase 1 autoimmune program targeting CD19. Capstan’s...

Cutting-edge genomic studies from the Wellcome Sanger Institute, University of Cambridge, and Cambridge University Hospitals reveal distinct mutational signatures caused by various chemotherapy...

Beckley Psytech and Atai Life Sciences have reported promising results from mid-stage clinical trials of psychedelic-based treatments targeting treatment-resistant depression. Beckley's intranasal...

The biotech sector is seeing rapid innovation at the intersection of artificial intelligence (AI) and genomics. Advances include AI-powered molecular diagnostics, computational drug discovery, and...

Beckley Psytech has reported positive Phase 2b clinical trial results for its intranasal psychedelic compound BPL-003 in patients with treatment-resistant depression. The trial demonstrated...

AbbVie announced a $2.1 billion acquisition of Capstan Therapeutics, gaining rights to a phase 1-stage in vivo CAR-T therapy targeting CD19 and Capstan’s proprietary targeted lipid nanoparticle...

Moderna reported positive Phase 3 data for its seasonal influenza vaccine mRNA-1010, demonstrating a 26.6% relative efficacy over a standard-dose comparator in adults 50 years and older across...

Recent studies have uncovered key mechanisms impacting various cancers and neurodegenerative diseases. Groundbreaking research highlights the role of mutant p53 and SH3BGRL in cancer cell...

Innovations in artificial intelligence are reshaping diagnostics and therapy. A new AI-driven system from Kindai University enhances classification of facial pigmented lesions, while University of...

Pharma companies face notable hurdles as INmune Bio’s Alzheimer’s disease program missed key Phase 2 endpoints despite subgroup benefits, and Pfizer terminated one of two CD47 drug trials from its...

New research reveals critical roles for microbiota and environmental factors in human and ecological health. A mouse study demonstrated that human gut bacteria can bioaccumulate “forever...

Recent innovations in genome editing reveal transformative potential. Researchers introduced a near-infrared-activated chemically induced CRISPR system enabling precise spatiotemporal control of...

New clinical evidence expands indications for existing classes of drugs. A retrospective cohort study published in BMC Cancer suggests sodium-glucose cotransporter-2 inhibitors (SGLT2i), typically...